Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
To invite people, share this page:
                                           
About This Webinar

At Genezen we’re committed to helping companies bring their gene and cell therapies to market and we are expanding our capacity to offer new state of the art clean rooms in 2021. We offer process development, contract viral vector manufacturing, testing, and transduced cell manufacturing. We expedite your development timelines in compliance with GMP in Genezen facilities and through our partnerships with leading research institutions. Visit our website at www.genezenlabs.com or book a meeting with us at https://meetings.hubspot.com/katie271. Come to us with your viral vector and testing needs and we, with dedicated experts, will help advance your project efficiently and ensure you are ready for regulatory scrutiny and your clinical trial.

Language: English
Who can attend? Everyone
Featured Presenters
Webinar hosting presenter
Chief Commercial Officer
Katie joined Genezen after working in venture capital, on intellectual property commercialization at Indiana University and University of Michigan, and at the bench in cell biology.
Webinar hosting presenter
Chairman & CEO
Bill started in gene therapy in 2010 as President of Rimedion, then founded Genezen Laboratories in 2014.
Webinar hosting presenter
President & COO
Dave is President and COO of Genezen Labs. Previous experience includes directing the intellectual property and licensing office at Indiana University and bench research at Pfizer.
Webinar hosting presenter
Chief Business Officer
Rebecca developed her background of scientific, business and financial skills through bench research and technology commercialization at Washington University in St. Louis and Indiana University.
Webinar hosting presenter
Chief Scientific Officer
As CSO, Pratima brings her extensive experience from Covance and the Indiana University Vector Production Core, especially in assay development, validation and viral vector production, to Genezen.
Webinar hosting presenter
Director of Operations
John joined Genezen after working both in academic research labs and in CAP/CLIA regulated labs in the pharmaceutical industry.
Hosted By
ASGCT 23rd Annual Meeting  webinar platform hosts  Genezen Laboratories
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.
Documents